Amyloid deposition in cerebral vessels (CAA) is a constant feature in A? and non-A? cerebral amyloidosis. Notably, vascular and not parenchymal deposits appear today to be more sensitive predictors of dementia. Unrelated amyloid subunits produce similar lesions in medium/small cerebral vessels and, as often neglected, in capillaries, suggesting common pathogenic mechanisms. To date, it is neither clear why specific mutations predominantly associate with cerebrovascular pathology nor understood why the main phenotype for some vasculotropic variants is hemorrhage/ischemic stroke while for others is cognitive impairment. Co-localizing with the amyloid deposits there is also a group of so-called amyloid-associated components, among them markers of cellular stress and inflammation whose role as active key players in the processes of amyloidogenesis and cell toxicity is far from being defined. Complicating the picture, oligomerization/aggnegation but not fibrillization of amyloidogenic peptides appear to be a pre-requisite to exert both, their cytotoxicity and their ability to trigger an inflammatory response. Although these effects are partially studied in neurons and glial cells, little is known about these mechanisms in the cells forming the vessel wall. Intriguing as well is whether the presence of CAA genetic variants exerts enhanced detrimental effects on cell toxicity and differentially alters endothelium properties, e.g. monolayer permeability. We hypothesize that conformational transitions of amyloidogenic peptides are key elements responsible for the pathogenic vascular features characteristic of the CAA including, among others, protein oligomerization and amyloid formation, cell toxicity, complement activation and the induction of inflammation-related mechanisms. Accordingly, oligomeric and fibrillar assemblies of synthetic A? variants in the presence and absence of selected amyloid associated components will be tested for their ability to induce a cytotoxic effect on cerebral endothelial and smooth-muscle cells and elicit concomitant permeability alterations in endothelial monolayers (aiml) as well as to trigger complement activation and the release of vascular and glial inflammatory components which, in turn, may worsen the toxic phenotype (aim 2). When feasible, results will be validated with similar assemblies extracted from well typified CAA/AD cases. Whether or not specific membrane receptors / binding molecules are mediators of the cellular responses will be explored in aim 3.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS051715-03
Application #
7588070
Study Section
Brain Injury and Neurovascular Pathologies Study Section (BINP)
Program Officer
Jacobs, Tom P
Project Start
2007-06-15
Project End
2012-03-31
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
3
Fiscal Year
2009
Total Cost
$370,781
Indirect Cost
Name
New York University
Department
Pathology
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Dave, Mandar; Islam, Abul B M M K; Jensen, Roderick V et al. (2017) Proteomic Analysis Shows Constitutive Secretion of MIF and p53-associated Activity of COX-2-/- Lung Fibroblasts. Genomics Proteomics Bioinformatics 15:339-351
Fossati, Silvia; Giannoni, Patrizia; Solesio, Maria E et al. (2016) The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain. Neurobiol Dis 86:29-40
Todd, Krysti; Ghiso, Jorge; Rostagno, Agueda (2016) Oxidative stress and mitochondria-mediated cell death mechanisms triggered by the familial Danish dementia ADan amyloid. Neurobiol Dis 85:130-143
Hernandez-Guillamon, Mar; Mawhirt, Stephanie; Blais, Steven et al. (2015) Sequential Amyloid-? Degradation by the Matrix Metalloproteases MMP-2 and MMP-9. J Biol Chem 290:15078-91
Ghiso, Jorge; Fossati, Silvia; Rostagno, Agueda (2014) Amyloidosis associated with cerebral amyloid angiopathy: cell signaling pathways elicited in cerebral endothelial cells. J Alzheimers Dis 42 Suppl 3:S167-76
Doudevski, Ivo; Rostagno, Agueda; Cowman, Mary et al. (2014) Clusterin and complement activation in exfoliation glaucoma. Invest Ophthalmol Vis Sci 55:2491-9
Todd, Krysti; Fossati, Silvia; Ghiso, Jorge et al. (2014) Mitochondrial dysfunction induced by a post-translationally modified amyloid linked to a familial mutation in an alternative model of neurodegeneration. Biochim Biophys Acta 1842:2457-67
Fossati, Silvia; Todd, Krysti; Sotolongo, Krystal et al. (2013) Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid ? and the Asn23 Iowa mutation. Biochem J 456:347-60
Fossati, S; Ghiso, J; Rostagno, A (2012) TRAIL death receptors DR4 and DR5 mediate cerebral microvascular endothelial cell apoptosis induced by oligomeric Alzheimer's A?. Cell Death Dis 3:e321
Calero, Miguel; Rostagno, Agueda; Ghiso, Jorge (2012) Search for amyloid-binding proteins by affinity chromatography. Methods Mol Biol 849:213-23

Showing the most recent 10 out of 25 publications